Expression of MUC1 mucin on activated human T cells: Implications for a role of MUC1 in normal immune regulation

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4079-4081

  Agrawal, Babita ^a   Krantz, Mark J ^a   Parker, Joanne ^a   Longenecker, B Michael ^a  

^a Biomira Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN;

ARTICLE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; CA-15-3 ANTIGEN; DOWN-REGULATION; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 0032531005     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gendler, S. J., and Spicer, A. P. Epithelial mucin genes. Annu. Rev. Physiol., 57; 607-634, 1995.
2. Yamamoto, M., Bharti, A., Li, Y., and Kufe, D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J. Biol. Chem., 272: 12492-12494, 1997.
3. Zrihan-Licht, S., Baruch, A., Elroy-Stein, O., Keydar. I., and Wreschner, D. H. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEES Lett., 356: 130-136, 1994.
4. Mockensturm-Gardner, M., and Gendler, S. J. The role of MUC1 at the membrane may involve transduction of a signal. Mol. Biol. Cell, 7: 434a, 1996.
5. + lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy. Cancer Immunol. Immunother., 42: 303-309, 1996.
6. MacLean, G. D., Reddish, M. A., and Longenecker, B. M. Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients. J. Immunother., 20: 70-78, 1997.
7. Agrawal, B., Krantz, M. J., Reddish, M. A., and Longenecker, B. M. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med., 4: 43-49, 1998.
8. + T cells isolated from peripheral blood lymphocytes of normal donors. J. Immunol., 157: 3229-3234, 1996.
9. Reddish, M., Black, N., Almeida, A., Suresh, M. R., and Longenecker, B. M. Epitope mapping of MAb B27.29 within the peptide core of the malignant breast carcinoma-associated mucin antigen coded for the human MUC1 gene. J. Tumor Marker Oncol., 7: 19-27, 1992.
10. Ligtenberg, M. J-, Buijs, F., Vos, H. L., and Hilkens, J. Suppression of cellular aggregation by high levels of episialin. Cancer Res., 52: 2318-2324, 1992.
11. Wesseling, J., Van der Valk, S. W., Vos, H. L., Sonnenberg, A., and Hilkens, J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extra-cellular matrix components. J. Cell Biol., 129: 255-265, 1995.
12. Wesseling, J., Van der Valk, S. W., and Hilkens, J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/ MUC1. Mol. Biol. Cell, 7: 565-577, 1996.
13. Hayes, D. F., Silberstein, D. S., Rodrique, S. W., and Kufe, D. W. DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets. J. Immunol., 145: 962-970, 1990.
14. Ogata, S., Maimonis, P. J., and Itzkowitz, S. H. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. Cancer Res., 52: 4741-4746, 1992.
15. Zhang, K., Sikut, R., and Hansson, G. C. A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells. Cell. Immunol., 166: 158-165, 1997.
16. van de Wiel-van Kemenade, E-, Ligtenberg, M. J. L., de Boer, A. L., Buijs, R., Vos, H. L., Melief, C. J. M., Hilkens, J., and Figdor, C. G. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J. Immunol., 151: 767-776, 1993.